CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
Rectal cancer patients with a complete response after neoadjuvant therapy can be monitored with a watch-and-wait strategy. However, regrowth rates indicate that identification of patients with a pathological complete response (pCR) remains challenging. Targeted near-infrared fluorescence endoscopy i...
Main Authors: | Daan Linders, Marion Deken, Maxime van der Valk, Willemieke Tummers, Shadhvi Bhairosingh, Dennis Schaap, Gesina van Lijnschoten, Elham Zonoobi, Peter Kuppen, Cornelis van de Velde, Alexander Vahrmeijer, Arantza Farina Sarasqueta, Cornelis Sier, Denise Hilling |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/3/516 |
Similar Items
-
Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated <i>KRAS</i> in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas
by: Luogen Peng, et al.
Published: (2023-03-01) -
Research Progress of Targeting uPA-uPAR System in Tumor Therapy
by: CAI Weiwen, et al.
Published: (2023-02-01) -
Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
by: Zheng Jingying, et al.
Published: (2017-03-01) -
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells
by: Mariaevelina Alfieri, et al.
Published: (2022-04-01) -
The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression
by: Yosuke Kanno
Published: (2023-01-01)